UroGen Pharma (URGN) Return on Equity [ROE] (2017 - 2024)
UroGen Pharma's Return on Equity [ROE] was -1518.36% in Q4 2024, down 1105.03 percentage points from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Return on Equity [ROE] (2017 - 2024) Analysis & Trends
For FY2021, Return on Equity [ROE] at UroGen Pharma came in at -211.55%, down 118.67 percentage points from FY2020.
- Return on Equity [ROE] shows a five-year change of -199.64 percentage points (FY2016 to FY2021).
- In earlier years, Return on Equity [ROE] was -92.88% in FY2020 (-15.11 pp), -77.77% in FY2019 (+17.63 pp), -95.40% in FY2018 (-48.24 pp) and -47.16% in FY2017 (-35.25 pp).
- The Q4 2024 figure marks the lowest quarterly Return on Equity [ROE] in data going back to Q4 2017.
- The year-over-year drop in Return on Equity [ROE] has ranged between 23.80 percentage points (Q1 2020) and 435.60 percentage points (Q4 2021) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | UroGen Pharma | 1.24 Bn | 782.15 Mn | 81.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -1,517.83% |
| Sep 30, 2024 | -412.00% |
| Dec 31, 2021 | -556.28% |
| Sep 30, 2021 | -258.25% |
| Jun 30, 2021 | -169.05% |
| Mar 31, 2021 | -135.14% |
| Dec 31, 2020 | -118.49% |
| Sep 30, 2020 | -103.91% |
| Jun 30, 2020 | -88.63% |
| Mar 31, 2020 | -73.28% |
| Dec 31, 2019 | -53.61% |
| Sep 30, 2019 | -41.12% |
| Jun 30, 2019 | -37.85% |
| Mar 31, 2019 | -50.79% |
| Dec 31, 2018 | -78.02% |
| Sep 30, 2018 | -57.02% |
| Jun 30, 2018 | -35.11% |
| Mar 31, 2018 | -31.03% |
| Dec 31, 2017 | -27.60% |
| Sep 30, 2017 | 4.00% |
API Access
UroGen Pharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();